Home » Topics » Hematologic, BioWorld Science

Hematologic, BioWorld Science
RSS

Centocor completes acquisition of reteplase

March 16, 1998

Improved anticoagulants in development at Gyogyszerkutato Intezet

March 16, 1998

Treatment of acute coronary syndromes by thrombin inhibition

March 16, 1998

Boehringer Ingelheim discloses new antiplatelet agents

March 13, 1998

Antithrombotics developed at Warner-Lambert

March 12, 1998

First Rx for HIT type II approved in U.S.

March 10, 1998

U.S. patent covers use of MH-1 to deliver thrombolytics

March 5, 1998

3-D reveals new trypsin-like serine protease inhibitors

March 4, 1998

Acetaminophen increases risk of hemorrhage in combination with warfarin

March 4, 1998

Anticoagulants under development at Astra

March 3, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 27, 2026.
ADPD 2026: Three inflection points to target Alzheimer’s disease
BioWorld Science
A new way of understanding Alzheimer’s disease, based on biological inflection points that mark decisive moments in the progression of the disorder, could change...
Emerging therapeutic strategies for Parkinson’s at ADPD 2026
BioWorld
Parkinson’s disease (PD) involves the progressive loss of dopaminergic neurons, particularly in the substantia nigra. This neurodegeneration is linked to the...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 24, 2026
SERCA inhibitor shows promise for MSA-C treatment
BioWorld Science
At the ongoing International Conference on Alzheimer’s and Parkinson’s Diseases and Related Neurological Disorders (AD/PD 2026) in Copenhagen, researchers...